In this presentation, Anand A. Patel, MD, reviewed the contemporary standard-of-care treatment roadmap for AML in 2025, covering key phases like induction chemotherapy (eg, the “7+3” regimen), consolidation…
Eunice S. Wang, MD, Roswell Park Comprehensive Cancer Center, Buffalo, New York, discusses the treatment strategies for patients who develop secondary acute myeloid leukemia (AML) following hypomethylating agent…
NEW YORK (Reuters Health) – Stereotactic body radiotherapy (SBRT) may be an effective alternative to surgery for solitary pulmonary nodules clinically diagnosed as lung cancer, researchers from Japan…
NEW YORK (Reuters Health) – Adding the multitargeted tyrosine kinase inhibitor sunitinib (Sutent; Pfizer) to docetaxel did not improve clinical outcomes when used in the first-line setting in…
NEW YORK (Reuters Health) – Some elderly patients with unresected non-small cell lung cancer (NSCLC) may do better with chemoradiotherapy (CRT) than with radiotherapy (RT) alone. However, low…
NEW YORK (Reuters Health) – While treatment of several malignancies with VEGFR (vascular endothelial growth factor receptor) tyrosine kinase inhibitors has improved patient outcomes, the agents are associated…
NEW YORK (Reuters Health) – The risk of cancer recurrence is increased slightly after laparoscopic rather than open surgical management of uterine cancer, according to study findings reported…
NEW YORK (Reuters Health) – The risk of cancer recurrence is increased slightly after laparoscopic rather than open surgical management of uterine cancer, according to study findings reported…
NEW YORK (Reuters Health) – About one in four patients with peripheral T-cell lymphoma (PTCL) who do not respond to or relapse after systemic therapy are likely to…
NEW YORK (Reuters Health) – Women with early-stage estrogen receptor-positive breast cancer fare somewhat better with 2 years of tamoxifen followed by 3 years of anastrozole than with…
NEW YORK (Reuters Health) – Intraoperative complications are similar whether staging of endometrial cancer is performed laparoscopically or by laparotomy, but laparoscopy has the advantage when it comes…
NEW YORK (Reuters Health) – Results of a study suggest that gonadotropin-releasing hormone (GnRH) agonist therapy does not help preserve ovarian function in young women undergoing modern chemotherapy…
